Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†

Open Access
Publisher Website
Google Scholar
Abstract
Treatment with benzarone or benzbromarone can be associated with hepatic injury. Both drugs share structural similarities with amiodarone, a well‐known mitochondrial toxin. Therefore, we investigated the hepatotoxicity of benzarone and benzbromarone as well as the analogues benzofuran and 2‐butylbenzofuran. In isolated rat hepatocytes, amiodarone, benzarone, and benzbromarone (20 μmol/L) decreased mitochondrial membrane potential by 23%, 54% or 81%, respectively. Benzofuran and 2‐butylbenzofuran had no effect up to 100 μmol/L. In isolated rat liver mitochondria, amiodarone, benzarone, and benzbromarone, but not benzofuran, decreased state 3 oxidation and respiratory control ratios for L‐glutamate (50% decrease of respiratory control ratio at [μmol/L]: amiodarone, 12.9; benzarone, 10.8; benzbromarone, <1). Amiodarone, benzarone, and benzbromarone, but not benzofuran, also uncoupled oxidative phosphorylation. Mitochondrial β‐oxidation was decreased by 71%, 87%, and 58% with 100 μmol/L amiodarone or benzarone and 50 μmol/L benzbromarone, respectively, but was unaffected by benzofuran, whereas ketogenesis was not affected. 2‐Butylbenzofuran weakly inhibited state 3 oxidation and β‐oxidation only at 100 μmol/L. In the presence of 100 μmol/L amiodarone, benzarone or benzbromarone, reactive oxygen species production was increased, mitochondrial leakage of cytochrome c was induced in HepG2 cells, and permeability transition was induced in isolated rat liver mitochondria. At the same concentrations, amiodarone, benzarone, and benzbromarone induced apoptosis and necrosis of isolated rat hepatocytes. In conclusion, hepatotoxicity associated with amiodarone, benzarone, and benzbromarone can at least in part be explained by their mitochondrial toxicity and the subsequent induction of apoptosis and necrosis. Side chains attached to the furan moiety are necessary for rendering benzofuran hepatotoxic. (HEPATOLOGY 2005.)
Funding Information
  • Swiss National Science Foundation (3100-59812-03/1)